[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

RU95101041A - Липосомные растворы - Google Patents

Липосомные растворы

Info

Publication number
RU95101041A
RU95101041A RU95101041/14A RU95101041A RU95101041A RU 95101041 A RU95101041 A RU 95101041A RU 95101041/14 A RU95101041/14 A RU 95101041/14A RU 95101041 A RU95101041 A RU 95101041A RU 95101041 A RU95101041 A RU 95101041A
Authority
RU
Russia
Prior art keywords
liposome solutions
liposome
solutions containing
relates
beta
Prior art date
Application number
RU95101041/14A
Other languages
English (en)
Inventor
Ферне Мишель
Fr]
Штеффен Ханс
Суперсаксо Андреас
Ch]
Тайль Франк-Петер
De]
Original Assignee
Ф.Хоффманн-Ля Рош Аг (Ch)
Ф.Хоффманн-Ля Рош Аг
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ф.Хоффманн-Ля Рош Аг (Ch), Ф.Хоффманн-Ля Рош Аг filed Critical Ф.Хоффманн-Ля Рош Аг (Ch)
Publication of RU95101041A publication Critical patent/RU95101041A/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/28—Steroids, e.g. cholesterol, bile acids or glycyrrhetinic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dispersion Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Изобретение относится к водным липосомным растворам, содержащим ингибитор бета-лактамазы и при определенных условиях бета-лактамантибиотик.

Claims (1)

  1. Изобретение относится к водным липосомным растворам, содержащим ингибитор бета-лактамазы и при определенных условиях бета-лактамантибиотик.
RU95101041/14A 1994-01-25 1995-01-23 Липосомные растворы RU95101041A (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH213/94 1994-01-25
CH21394 1994-01-25

Publications (1)

Publication Number Publication Date
RU95101041A true RU95101041A (ru) 1997-02-27

Family

ID=4181848

Family Applications (1)

Application Number Title Priority Date Filing Date
RU95101041/14A RU95101041A (ru) 1994-01-25 1995-01-23 Липосомные растворы

Country Status (10)

Country Link
EP (1) EP0664117A1 (ru)
JP (1) JPH07206713A (ru)
KR (1) KR950031041A (ru)
CN (1) CN1111125A (ru)
AU (1) AU699142B2 (ru)
BR (1) BR9500296A (ru)
CA (1) CA2140701A1 (ru)
NZ (1) NZ270362A (ru)
RU (1) RU95101041A (ru)
ZA (1) ZA95404B (ru)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9616536D0 (en) 1996-08-06 1996-09-25 Quadrant Holdings Cambridge Co-amoxiclav dosage form
US7378408B2 (en) * 2001-11-30 2008-05-27 Pfizer Inc. Methods of treatment and formulations of cephalosporin
CN102048740B (zh) * 2010-12-02 2012-06-13 郝志艳 头孢曲松钠他唑巴坦钠药物组合物脂质体注射剂
WO2013036783A2 (en) 2011-09-09 2013-03-14 Cubist Pharmaceuticals, Inc. Methods for treating intrapulmonary infections
US8809314B1 (en) 2012-09-07 2014-08-19 Cubist Pharmacueticals, Inc. Cephalosporin compound
US8476425B1 (en) 2012-09-27 2013-07-02 Cubist Pharmaceuticals, Inc. Tazobactam arginine compositions
CN102973568B (zh) * 2012-12-10 2014-08-27 江苏开元医药化工有限公司 头孢曲松钠舒巴坦钠的药物组合物脂质体的制备方法
US9872906B2 (en) 2013-03-15 2018-01-23 Merck Sharp & Dohme Corp. Ceftolozane antibiotic compositions
AU2014227660B2 (en) 2013-03-15 2014-11-06 Merck Sharp & Dohme Llc Ceftolozane antibiotic compositions
US20140274993A1 (en) 2013-03-15 2014-09-18 Cubist Pharmaceuticals, Inc. Ceftolozane-tazobactam pharmaceutical compositions
WO2015035376A2 (en) 2013-09-09 2015-03-12 Calixa Therapeutics, Inc. Treating infections with ceftolozane/tazobactam in subjects having impaired renal function
US8906898B1 (en) 2013-09-27 2014-12-09 Calixa Therapeutics, Inc. Solid forms of ceftolozane
CN112791074B (zh) * 2021-03-17 2022-10-04 中山大学 鱼腥草素和/或新鱼腥草素钠在制备ndm-1抑制剂中的用途

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1237671A (en) * 1983-08-01 1988-06-07 Michael W. Fountain Enhancement of pharmaceutical activity
IE58981B1 (en) * 1985-10-15 1993-12-15 Vestar Inc Anthracycline antineoplastic agents encapsulated in phospholipid micellular particles
EP0479582A1 (en) * 1990-10-03 1992-04-08 Alexander Karl Friedrich Wilhelm Overweg Restorative periodontal technique

Also Published As

Publication number Publication date
AU699142B2 (en) 1998-11-26
JPH07206713A (ja) 1995-08-08
BR9500296A (pt) 1995-10-17
EP0664117A1 (de) 1995-07-26
NZ270362A (en) 1996-10-28
KR950031041A (ko) 1995-12-18
CN1111125A (zh) 1995-11-08
ZA95404B (en) 1995-07-25
AU1029895A (en) 1995-08-03
CA2140701A1 (en) 1995-07-26

Similar Documents

Publication Publication Date Title
RU94028653A (ru) Фармацевтический препарат
RU95101041A (ru) Липосомные растворы
ATE248856T1 (de) Derivate von glycopeptid-antibiotika
RU94046294A (ru) Стероидные гликозиды для лечения гиперхолестеринэмии
RU95114376A (ru) Нитроэфиры, обладающие фармакологической активностью, и способ их получения
DK1109812T3 (da) Pyrrolobenzodiazepiner
DK0582829T3 (da) 9-(Substitueret glycyl)amido-6-demethyl-6-deoxytetracycliner som antibiotiske midler
ES2191208T3 (es) Oxiimino-pregnano-carbolactonas.
DK0747393T3 (da) Dobbeltvirkende inhibitorer indeholdende en thiazolobenzazepinstruktur
MX9708696A (es) Cefalosporinas antibacterianas.
DK0747392T3 (da) Dobbeltvirkende inhibitorer indeholdende 1,2-diazepiner
DK0586663T3 (da) Carbapenem-derivater som antibiotika samt mellemprodukter dertil
DE69600244D1 (de) Basische prolinamid derivate von ge2270 und ge2270-ahnlichten antibiotika
ATE205505T1 (de) Basische oxazolinamid-derivate von ge2270 und ge2270-änlichen antibiotika
ATE96845T1 (de) Teicoplaninaehnliche derivate.
ITMI922296A0 (it) Procedimento per la preparazione di antibiotici beta-lattamici sterili
ATE231510T1 (de) Penamsulfone als beta-laktamase inhibitoren
AU6206486A (en) P-acylaminobenzamides
RU94028649A (ru) Оксимные производные с цефалоспорановой структурой, способ их получения и промежуточные соединения
ES2092569T3 (es) Mejoras introducidas en electrodos de vidrio para ph.
RU94028126A (ru) Средство, обладающее иммуномодулирующей активностью
ATE112777T1 (de) Kristalline (5r,6s)-2-carbamoyloxymethyl-6-((1r)- hydroxyäthyl>-2-penem-3-carbonsäure und ihre pharmazeutische präparate.
FI934468A0 (fi) Bensenborsyraderivat, foerfarande foer deras framstaellning och deras anvaendning som sytesmellanprodukter
IT1207578B (it) Antibiotici carbapenem e relativo procedimento di preparazione.
PT83712B (pt) Processo para a preparacao de derivados de cefalosporina